TrialJournal for immunotherapy of cancer2025

Multicenter phase II trial of ipilimumab and nivolumab in metastatic or unresectable perivascular epithelioid cell tumor (PEComa): a substudy of

Sandip P Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.